93 related articles for article (PubMed ID: 22774522)
1. [Nuclear medicine in radiotherapy planning for patients with malignant neoplasms of different locations].
Kanaev SV; Novikov SN; Girshovich MM; Krivorot'ko PV; Beĭnusov DS; Krzhivitskiĭ PI
Vopr Onkol; 2012; 58(2):189-93. PubMed ID: 22774522
[TBL] [Abstract][Full Text] [Related]
2. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
[TBL] [Abstract][Full Text] [Related]
3. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
4. [Role of radionuclide imaging of bone marrow and spleen in choice of therapy and topometric preparation for radiotherapy of patients with Hodgkin disease].
Kanaev SV; Novikov SN; Gershanovich ML; Zhukova LA; Korobova IA
Vopr Onkol; 2002; 48(2):193-5. PubMed ID: 12227067
[TBL] [Abstract][Full Text] [Related]
5. A comparison of internal target volume definition by limited four-dimensional computed tomography, the addition of patient-specific margins, or the addition of generic margins when planning radical radiotherapy for lymph node-positive non-small cell lung cancer.
Hughes S; McClelland J; Chandler A; Adams M; Boutland J; Withers D; Ahmad S; Blackall J; Tarte S; Hawkes D; Landau D
Clin Oncol (R Coll Radiol); 2008 May; 20(4):293-300. PubMed ID: 18234482
[TBL] [Abstract][Full Text] [Related]
6. [The use of PET/CT in radiotherapy of patients with non-small cell lung cancer].
Lõcsei Z; Hideghéty K; Farkas R; Bellyei S; Sárosi V; Sebestyén K; Sebestyén Z; Kovács P; Mangel L
Magy Onkol; 2011 Nov; 55(4):274-80. PubMed ID: 22128310
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.
Aristophanous M; Berbeco RI; Killoran JH; Yap JT; Sher DJ; Allen AM; Larson E; Chen AB
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e99-105. PubMed ID: 21377285
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?
Bardiès M; Buvat I
Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):5-20. PubMed ID: 21386782
[No Abstract] [Full Text] [Related]
9. [Lymphoscintigraphy of separate lymph nodes for radiotherapy planning in breast cancer].
Kanaev SV; Novikov SN; Zhukova LA; Zotova OV; Semiglazov VF; Krivorot'ko PV
Vopr Onkol; 2011; 57(5):616-21. PubMed ID: 22238932
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
Maraldo MV; Dabaja BS; Filippi AR; Illidge T; Tsang R; Ricardi U; Petersen PM; Schut DA; Garcia J; Headley J; Parent A; Guibord B; Ragona R; Specht L
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):144-52. PubMed ID: 25670544
[TBL] [Abstract][Full Text] [Related]
11. Scintimammography and single-photon emission computed tomography for postoperative image guidance for radiation treatment planning in breast cancer patients.
Piperkova E; Chavdarova L; Garanina Z; Gocheva L; Parvanova V; Tzonevska A; Dimitrova M
J BUON; 2011; 16(4):657-63. PubMed ID: 22331718
[TBL] [Abstract][Full Text] [Related]
12. [Combined bone marrow and skeletal scintigraphy in osseous and myelogenous diseases].
Hotze A; Löw A; Mahlstedt J; Wolf F
Rofo; 1984 Jun; 140(6):717-23. PubMed ID: 6234628
[TBL] [Abstract][Full Text] [Related]
13. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
[TBL] [Abstract][Full Text] [Related]
15. Cardiac localization of 99mTc-(Sn)-pyrophosphate following irradiation of the chest.
Soin JS; Cox JD; Youker JE; Swartz HM
Radiology; 1977 Jul; 124(1):165-8. PubMed ID: 194274
[TBL] [Abstract][Full Text] [Related]
16. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
19. Workflow and radiation safety implications of (18)F-FDG PET/CT scans for radiotherapy planning.
Sam S; Shon IH; Vinod SK; Lin P; Lin M
J Nucl Med Technol; 2012 Sep; 40(3):175-7. PubMed ID: 22582005
[TBL] [Abstract][Full Text] [Related]
20. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]